Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Balmex is a topical skin protectant brand, specifically known for its diaper rash treatments, developed by Randob Labs (now CrossingWell Consumer Health). The primary active ingredient is zinc oxide (11.3%), which functions as a physical barrier to protect skin from wetness, chafing, and irritants such as digestive enzymes found in soiled diapers. The formulation features "ActivGuard" technology, incorporating botanical extracts like Evening Primrose and Olive leaf, along with vitamins B5 (panthenol) and E (tocopherol) to soothe and nourish irritated skin. It is clinically proven to reduce redness in as little as one diaper change and has been a pediatrician-recommended product for over 50 years.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Balmex.